Last updated: 2026-09-22 09:43:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $62.60, with a market capitalization of $128.81B and a P/E ratio of 13.78. Over the past 52 weeks, its price has ranged from $42.52 to $68.64. This page covers its latest market performance, valuation, price trends and company information.
$128.81B | |
$62.81 | |
$81.44 | |
$16.00 | |
$62.62 | |
3.31K | |
11.09M | |
13.78 | |
$68.64 | |
$42.52 | |
3.98% | |
-- |
Bristol-Myers Squibb Co. (BMY) is trading at $62.60 in pre-market trading as of 2026-09-22 09:38:00, down 0.04% ($0.02) from the previous close of $62.62
Pre-market trading shows how investors are pricing BMY before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Bristol-Myers Squibb Co. (BMY) moved from $63.64 to $62.60, representing a decline of 1.64% ($1.05).
The stock traded between $62.19 and $65.29 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 12.76 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 76.9%
BMY is currently trading at $62.60, placing it 76.9% of the way from its 52-week low of $42.52 to its 52-week high of $68.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 32500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Bristol-Myers Squibb Co. (BMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.